Danaher Corporation Share Price & Technical Analysis

DHR · $172.0 (-0.77%)

Healthcare / Diagnostics & Research

AI Score 31 · Bearish

$172.0

-0.77%

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the developmen

Price chart

Seasonality

May has 2 positive and 3 negative years (last 5 years shown)

-4% return in May, -1% avg return in past 3 year May month.

-28% return in 2026, 3% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
26-4%-4%-9%-6%-4%-28%
25-4%-5%-2%-3%-4%5%0%5%-3%8%6%1%6%
244%6%-1%-1%4%-3%11%-4%4%-12%-4%-4%1%
23-1%-7%3%-5%-4%5%7%4%-7%-12%16%4%2%
22-13%-5%7%-15%5%-7%15%-7%-4%-4%8%-4%-22%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 31/100

Bearish · Downtrend · Neutral

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

$118.03B

P/E ratio

32.32

52W high

$242.8

52W low

$160.9

Volume

29,94,948

Beta

0.84

Related stocks in Healthcare

Frequently asked questions

What is Danaher Corporation share price today?
Danaher Corporation (DHR) last traded around $172.0 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does DHR have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for DHR. Download the app for real-time alerts.
How can I analyze Danaher Corporation stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro